Navigation Links
Another Use For Epilepsy Drugs

Based on finding of a recent study researchers say the drug gabapentin (Neurontin) taken at 2,400 milligrams a day is an effective preventive // measure for people with chronic daily headaches.

Gabapentin is an approved anti-epileptic drug. Studies have also shown its success in treating other pain-related health issues like diabetic neuropathy, postherpetic neuralgia, and migraine headache. Since gabapentin often reduces migraines by more than 50 percent and chronic daily headaches often have migraine-like features, researchers in Australia conducted a double-blind, placebo-controlled study to determine the drug's specific effect on chronic daily headaches. This type of study is the gold standard of clinical research studies where neither the researchers nor the participants know who received the drug or an identical dummy substance, called a placebo.

For the study researchers recruited 133 patients who had headaches at least 15 days every month that lasted more than four hours at a time. The patients were randomly selected to receive gabapentin or a placebo for six weeks. After that period, none of the patients received either treatment for a week, and then each group switched to the opposite treatment for a second six weeks.

Results showed 36 percent of the patients taking 2,400 milligrams of gabapentin a day stopped having chronic daily headaches. Negative effects of the drug included vomiting, dizziness, dysarthria (problems speaking), sleepiness, and constipation.
'"/>




Page: 1

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. The Possibility Of Fighting HIV with Another Virus Questioned
4. New Research Has Found Another Use For Botox
5. Yet Another Harmful Consequence Of Smoking
6. Another Treatment Option for Benign Tumors
7. Yet Another Treatment Option For Cancer
8. Another Alternative For Diabetics On Insulin
9. Another Cause of Thyroid Cancer Discovered
10. Yet Another Use For Cell Phone Cameras
11. Yet Another Use For Cocoa Flavonols

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Another Use For Epilepsy Drugs

(Date:11/8/2009)... Men’s Health Network (MHN) urges milita...ecially those linked to exposure to chemicals, ato.... Bladder cancer is one of those cancers that is t...ose who once smoked or currently smoke cigarettes....November 8, 2009 -- Men’s Health Network (MH...
(Date:11/8/2009)...st network of Hispanic health advocates committed ... ,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/...wed they have heard the voice of America,s familie...a Act. Now the Senate must deliver, without delay,... said Dr. Jane L. Delgado, President and CEO of th...
(Date:11/8/2009).... 8 The following was r...n Rescue Insurrecta Nex. ,, Mr. Terry and his ...ing to keep child-killing by abortion out of any h...: "This is a great first step to victory -- a touc... fighting ahead of us. Our rejoicing must be tempe...
(Date:11/8/2009)...f., Nov. 8 March of Dim...luncheon to recognize prominent individuals who ar...are role models for March of Dimes commitment to i... of Dimes November Prematurity Awareness Month cam...o join the fight for preemies! ,, (Photo: htt...
(Date:11/7/2009)... The American Medical A...ector of Health at the Family Violence Prevention ...today at its semi-annual policy-making meeting. T...st honor the AMA House of Delegates bestows on a n....com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ms. ...
Breaking Medicine News(10 mins):Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Family Violence Prevention Expert 2
... of California, INDIANAPOLIS, Jan. 9 WellPoint, ...si has been appointed president and,chief executiv... which,includes the Individual, Senior and State S...r to retire in 2008. Sassi will,begin transitionin...
...Gary,Tschautscher received the highly regarded Ind... North American Patient Monitoring Industry from F...anding industry achievements in,regional and globa...nored Tschautscher for his pioneering vision and,s...
...d of cooking at home continues to increase as a fa... large variety of food options and food establishm...available restaurants matter to Americas rising ob... fast food?restaurants compared to full service?re...
...dicines more often , TUESDAY, Jan. 8 (HealthDay Ne...with diabetes, high blood pressure and other chron...ines, suggests a new study led by University of Mi...osts of health insurance by making workers and ret...
...titive Analysis Information Fro...NDON, Jan. 9 Thomson,Scientific, part of The Thom...g provider of information solutions to the worldwi... U.S. generics,market from July to September 2007,...
... of the Medicare Prescription Drug Benefit (Part D...crease in out-of-pocket expenses for patients and ...earchers from the University of Chicago Medical Ce...enefit plan. They compare out-of-pocket costs and ...
Other Medicine News:Health News:WellPoint Appoints Brian A. Sassi as President and CEO of the Company's Consumer Business Unit 2Health News:WellPoint Appoints Brian A. Sassi as President and CEO of the Company's Consumer Business Unit 3Health News:Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan 2Health News:Eating out can have both positive and negative impact on obesity 2Health News:Lowering Co-Pays on Some Drugs Help Fight Chronic Diseases 2Health News:Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry 2Health News:Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry 3Health News:Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry 4Health News:First rigorous analysis defines impact of Medicare Part D 2
(Date:11/6/2009)...Nov. 6 GeoVax Labs, Inc...mpany"), an Atlanta-based, biopharmaceutical compa...y HIV-1 (Human Immunodeficiency Virus) and other i...r 2009 financial results and provided an operation...and Chief Executive Officer commented, "We are ple...
(Date:11/6/2009)..., November 6 , - Trial Wi...d for the,Treatment of Multi-Resistant Staphylococ... speciality pharmaceutical company focused on the ...igned to overcome the significant global,problem o...ost advanced oral,antibacterial NXL103 (flopristin...
(Date:11/5/2009)...ntario, Nov. 5 Helix Bio...unced today that its Phase II trial of Topical Int...warts (AGW) has completed patient enrollment, with...e trial. ,, The double-blind and placebo-contro...s in Germany and Sweden. Patients participating i...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6AACR to host Frontiers in Basic Cancer Research meeting 58691 1Self monitoring of blood glucose levels helps patients with diabetes 58686 1Ardi displaces Lucy as oldest hominid skeleton 10222 1Ardi displaces Lucy as oldest hominid skeleton 10222 2Ardi displaces Lucy as oldest hominid skeleton 10222 3Ardi displaces Lucy as oldest hominid skeleton 10222 4Ardi displaces Lucy as oldest hominid skeleton 10222 5
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
...s is a national reference laboratory and a worldwi...velopment. ARUP offers an extensive test menu of h... and anatomic pathology. Owned by the University o...an half of the nation's university teaching hospit...
Medicine Products: